Cargando…
Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses
The rational development of norovirus vaccine candidates requires a deep understanding of the antigenic diversity and mechanisms of neutralization of the virus. Here, we isolate and characterize a panel of broadly cross-reactive naturally occurring human monoclonal IgMs, IgAs and IgGs reactive with...
Autores principales: | Alvarado, Gabriela, Salmen, Wilhelm, Ettayebi, Khalil, Hu, Liya, Sankaran, Banumathi, Estes, Mary K., Venkataram Prasad, B. V., Crowe, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280134/ https://www.ncbi.nlm.nih.gov/pubmed/34262046 http://dx.doi.org/10.1038/s41467-021-24649-w |
Ejemplares similares
-
Author Correction: Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses
por: Alvarado, Gabriela, et al.
Publicado: (2021) -
Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses
por: Ettayebi, Khalil, et al.
Publicado: (2022) -
A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity
por: Salmen, Wilhelm, et al.
Publicado: (2023) -
Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity
por: Hu, Liya, et al.
Publicado: (2022) -
Novel fold of rotavirus glycan-binding domain predicted by AlphaFold2 and determined by X-ray crystallography
por: Hu, Liya, et al.
Publicado: (2022)